COO Stock Forecast: The Cooper Cos., Inc. Price Predictions for 2026-2027
The 17 Wall Street analysts covering The Cooper Cos., Inc. hold a median 12-month price target of $65 — +10.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 71 of 100 as at 21 Nov 2026 — in the upper half. Here, the model and the Street point the same way.
One number for the whole business
Consensus tells you what everyone already believes. The model scores The Cooper Cos., Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (97): The share price has been relatively steady.
Momentum (39): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
COO stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on COO, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +10.4% from it.
Of the 20 most recent actions, 2 moved their price target up and 10 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 7 Oct 2026 | Barclays | Initiates | Equal-Weight | $60 |
| 15 Sept 2026 | Needham | Reiterates | Buy | $73 |
| 11 Sept 2026 | Mizuho | Maintains | Outperform | $85 → $75 |
| 10 Sept 2026 | B of A Securities | Downgrade | Neutral | $80 → $65 |
| 10 Sept 2026 | Baird | Downgrade | Neutral | $85 → $61 |
| 10 Sept 2026 | Citigroup | Maintains | Neutral | $80 → $60 |
| 10 Sept 2026 | JP Morgan | Maintains | Neutral | $71 → $58 |
| 10 Sept 2026 | Needham | Maintains | Buy | $86 → $73 |
| 10 Sept 2026 | Piper Sandler | Downgrade | Neutral | $86 → $59 |
| 10 Sept 2026 | Stifel | Maintains | Buy | $85 → $70 |
| 10 Sept 2026 | UBS | Maintains | Neutral | $75 → $66 |
| 10 Sept 2026 | Wells Fargo | Maintains | Equal-Weight | $66 → $61 |
| 10 Sept 2026 | William Blair | Downgrade | Market Perform | — |
| 13 Aug 2026 | Citigroup | Maintains | Neutral | $76 → $80 |
| 28 July 2026 | UBS | Initiates | Neutral | $75 |
| 8 July 2026 | Citigroup | Maintains | Neutral | $69 → $76 |
| 8 June 2026 | BNP Paribas | Maintains | Outperform | — |
| 5 June 2026 | Baird | Maintains | Outperform | — |
| 5 June 2026 | JP Morgan | Maintains | Neutral | — |
| 5 June 2026 | Needham | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for COO.
This page is one stock. Monday covers all of them.
COO appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
COO vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, The Cooper Cos., Inc. returned −17.2% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
COO analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 20.8×
- Price / sales
- 2.7×
- Price / book
- 1.4×
- EV / EBITDA
- 15.1×
Cheaper than 43% of US stocks
Cheaper than 40% of US stocks
Cheaper than 57% of US stocks
Cheaper than 33% of US stocks
- Revenue growth (YoY)
- 0.6%
- Earnings growth (YoY)
- 340.3%
- Gross margin
- 66.8%
- Operating margin
- 12.9%
- Net margin
- 13.5%
Higher than 30% of US stocks
Higher than 93% of US stocks
Higher than 80% of US stocks
Higher than 69% of US stocks
Higher than 74% of US stocks
- Return on equity
- 6.8%
- Return on assets
- 2.7%
- Dividend yield
- 0.1%
Higher than 55% of US stocks
Higher than 62% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
The Cooper Cos., Inc. has a market value of $11.5B and an enterprise value of $14.1B.
Revenue in the twelve months to 31 July 2026: $4.2B. The latest quarter grew 0.6% year on year.
Net income over the same four quarters: $570.3M, a 13.5% net margin.
Diluted earnings per share, trailing twelve months: $2.93.
Free cash flow in the twelve months to 31 July 2026: $678.0M.
The Cooper Cos., Inc. spent $644.0M on share buybacks in the twelve months to 31 July 2026.
Trailing P/E: 20.8×; forward P/E: 12.9× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.10%.
The Cooper Cos., Inc. employs 15,000 people — $282K of revenue per employee.
Data provided by Twelve Data
COO and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at COO’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own The Cooper Cos., Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about COO
What is the COO stock price forecast for 2026-2027?
The 17 Wall Street analysts covering The Cooper Cos., Inc. have a median 12-month price target of $65, with estimates ranging from $58 to $75. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is COO stock a buy right now?
Of the 17 analysts covering The Cooper Cos., Inc., 5 rate it a Buy, 12 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks The Cooper Cos., Inc. 71 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank COO?
As at 21 Nov 2026, The Cooper Cos., Inc. ranks 71 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Volatility (97 of 100).
Will COO stock go up?
No one can know that. What the data says: the median 12-month target from 17 analysts implies +10.4% from the last close, and Ticker Nerd's factor model ranks The Cooper Cos., Inc. 71 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the COO stock forecast for 2030?
No analyst covering The Cooper Cos., Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for COO are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $58 to $75 over the next 12 months.
How has COO stock performed over the past year?
The Cooper Cos., Inc. returned -17.2% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does The Cooper Cos., Inc. do?
The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. Through its CooperVision segment, the company develops, manufactures, and markets a broad range of contact lenses, including daily disposable, toric, multifocal, and specialty products designed to support different vision correction needs.
About The Cooper Cos., Inc.
The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. Through its CooperVision segment, the company develops, manufactures, and markets a broad range of contact lenses, including daily disposable, toric, multifocal, and specialty products designed to support different vision correction needs. Its CooperSurgical segment provides fertility, reproductive health, and women’s healthcare products and services, including medical devices, diagnostic tools, cryostorage solutions, and office-based surgical products. The Cooper Companies serves eye care professionals, fertility clinics, hospitals, and other healthcare providers across international markets. Headquartered in San Ramon, California, The Cooper Companies, Inc. plays an important role in specialized healthcare by combining consumer-facing vision products with clinical solutions for reproductive and women’s health.
CEO Mr. Albert G. White III · 15,000 employees · United States · https://www.coopercos.com